ABSTRACT
Describir las herramientas estadísticas las herramientas estadísticas empleadas para la presentación de resultados de investigación en los artículos publicados en la revista Archivos Argentinos de Pediatría a fin de evaluar el nivel y accesibilidad de aquéllas. Estudio observacional, descriptivo y retrospectivo. Se analizaron las publicaciones del período 2015-2019. Aplicando la escala de Mora Ripoll adaptada por Praena Fernández, fueron revisados 236 trabajos que cumplieron con los criterios de inclusión en la sección Artículos originales de la revista Archivos Argentinos de Pediatría. El 14,4% de los artículos correspondió al nivel I, 22,9% al nivel II y 62,7% al nivel III. Así, un lector cuyo repertorio de conocimientos estadísticos equivaliera al nivel I accedería al 14,4% de los artículos mientras que quien contara con un nivel II elevaría la accesibilidad al 37,3%. Del análisis de los artículos originales publicados en los AAP, resulta evidente que quien desee realizar un análisis crítico de la totalidad de los hallazgos presentados en la revista, deberá contar con un apropiado nivel de conocimiento que, lamentablemente, no suele alcanzarse en la carrera de grado de Medicina.
Describes the statistical tools used to present research results in articles published in the Argentine Archives of Pediatrics to assess their level and accessibility. Observational, descriptive and retrospective study. Publications for the period 2015-2019 were analyzed. Applying the Mora Ripoll scale, adapted by Praena Fernández, 236 papers satisfying the inclusion criteria were reviewed in its original articles section. 14.4% of the articles corresponded to level I, 22.9% to level II and 62.7% to level III. Thus, a reader whose repertoire of statistical knowledge equals level I would access 14.4% of the articles, while a reader with a level II would increase accessibility to 37.3%. From the analysis of the original articles published in the AAP, it is evident that anyone who wishes to carry out a critical analysis of all the findings presented in the journal, must have an appropriate level of knowledge that, unfortunately, it is not usually achieved in the undergraduate degree of Medicine.
Subject(s)
Humans , Periodicals as Topic , Biostatistics , Data Interpretation, Statistical , Comprehension , Pediatrics , Argentina , Professional Competence , Retrospective StudiesABSTRACT
Lagovirus is an emerging genus of Caliciviridae, which includes the Rabbit Hemorrhagic Disease Virus (RHDV) of rabbits and the European brown hare syndrome virus (EBHSV) of hares that cause lethal hepatitis. In 2010, a new RHDV related virus (RHDV2) with a unique genetic and antigenic profile and lower virulence was identified in France in rabbits. Here we report the identification of RHDV2 as the cause in Sardinia of several outbreaks of acute hepatitis in rabbits and Cape hare (Lepus capensis mediterraneus). This is the first account of a lagovirus that causes fatal hepatitis in both rabbits and hares.
Subject(s)
Caliciviridae Infections/veterinary , Hares , Hemorrhagic Disease Virus, Rabbit/physiology , Animals , Antibodies, Monoclonal/blood , Antibodies, Viral/blood , Caliciviridae Infections/epidemiology , Caliciviridae Infections/genetics , Caliciviridae Infections/virology , Cytochromes b/genetics , Cytochromes b/metabolism , Electron Transport Complex IV/genetics , Electron Transport Complex IV/metabolism , Enzyme-Linked Immunosorbent Assay/veterinary , Hemorrhagic Disease Virus, Rabbit/genetics , Hemorrhagic Disease Virus, Rabbit/metabolism , Italy/epidemiology , Molecular Sequence Data , Phylogeny , Sequence Analysis, Protein/veterinary , Viral Structural Proteins/genetics , Viral Structural Proteins/metabolismABSTRACT
The existence of non-pathogenic RHDV strains was established when a non-lethal virus named rabbit calicivirus (RCV) was characterised in 1996 in Italy. Since then, different RNA sequences related to RHDV have been detected in apparently healthy domestic and wild rabbits, and recently a new lagovirus was identified in Australia. We have characterised from seropositive healthy domestic rabbits a non-lethal lagovirus that differs from RHDV in terms of pathogenicity, tissue tropism and capsid protein sequence. Phylogenetic analyses have revealed that it is close to the Ashington strain and to the RCV, but distinct. We proved experimentally that it is infectious but non-pathogenic and demonstrated that, contrary to the other described non-pathogenic lagoviruses, it induces antibodies that do not protect against RHDV. Our results indicate the existence of a gradient of cross-protection between circulating strains, from non-protective, partially protective to protective strains, and highlight the extent of diversity within the genus Lagovirus.
Subject(s)
Bunyaviridae Infections/veterinary , Carrier State/veterinary , Lagovirus/classification , Lagovirus/isolation & purification , Animals , Antibodies, Viral/blood , Bunyaviridae Infections/immunology , Bunyaviridae Infections/virology , Carrier State/virology , Cluster Analysis , Cross Protection , Hemorrhagic Disease Virus, Rabbit/genetics , Lagovirus/genetics , Lagovirus/pathogenicity , Molecular Sequence Data , Phylogeny , RNA, Viral/genetics , Rabbits , Sequence Analysis, DNA , Sequence HomologyABSTRACT
Myxoma virus is a poxvirus responsible for myxomatosis in European Rabbits (Oryctolagus cuniculus). The entire genome of the myxoma virus has been sequenced, allowing a systemic survey of the functions of a large number of putative pathogenic factors that this virus expresses to subvert the immune and inflammatory pathways of infected rabbit hosts. In Italy, industrial rabbits are mostly vaccinated against myxomatosis using the attenuated myxoma virus strains Borghi or SG33. We have identified genetic markers specific for Borghi or SG33 vaccine strains and established a PCR-based assay that could be used to: (a) rapidly diagnose the presence of myxoma virus in infected organs; (b) discriminate between field strain-infected and vaccinated rabbits and (c) differentiate between Borghi or SG33 vaccine strain.
Subject(s)
Myxoma virus/genetics , Myxomatosis, Infectious/genetics , Viral Vaccines/genetics , Animals , Genetic Markers/immunology , Myxoma virus/immunology , Myxomatosis, Infectious/immunology , Myxomatosis, Infectious/prevention & control , Rabbits , Species Specificity , Viral Vaccines/immunology , Viral Vaccines/pharmacologyABSTRACT
In 2001, a compulsory active surveillance system was started in the European Union to assess the prevalence of bovine spongiform encephalopathy (BSE) in the cattle population. The aim of the current study was to report on the field performances of 3 rapid tests: a Western blot (WB), a chemiluminescence enzyme-linked immunosorbent assay (ELISA), and an immunochromatographic assay, routinely used at 3 laboratories of the Istituto Zooprofilattico Sperimentale of Lombardia and Emilia Romagna, over 8 years of BSE monitoring activity. A total of 2,802,866 samples from slaughtered animals and 202,453 samples from fallen stock were tested by 1 of 3 tests. Positive results of the rapid tests were confirmed by histopathological examination, immunohistochemistry, and confirmatory WB. The field performances (i.e., initial reactive and false-positive rates) and practical aspects regarding resources and applicability of the tests to high-throughput routine testing laboratories were evaluated. The 3 tests proved to be reliable tools when applied to slaughtered samples, showing no or very low false-positive rates (<1 per 100,000 negative samples tested) and low retesting frequencies (0.02-0.26%). When samples from fallen stock were analyzed, performances of the immunochromatographic assay, and especially the chemiluminescence ELISA, were negatively affected, resulting in higher false-positive and retesting rates. On the other hand, both tests are less expensive, much easier to use, provide more rapid results, and adapt well to application in routine laboratories as compared with WB. In the authors' experience, the immunochromatographic assay was a good compromise between performance and convenience.
Subject(s)
Encephalopathy, Bovine Spongiform/diagnosis , Abattoirs/standards , Animals , Antibodies, Monoclonal/blood , Blotting, Western , Cattle , Encephalopathy, Bovine Spongiform/immunology , Enzyme-Linked Immunosorbent Assay/methods , Italy , Luminescence , Monitoring, Physiologic/methods , Monitoring, Physiologic/veterinaryABSTRACT
Rabbit Hemorrhagic Disease (RHD) is a severe acute viral disease specifically affecting the European rabbit Oryctolagus cuniculus. As the European rabbit is the predominant species of domestic rabbit throughout the world, RHD contributes towards significant losses to rabbit farming industries and endangers wild populations of rabbits in Europe and other predatory animals in Europe that depend upon rabbits as a food source. Rabbit Hemorrhagic Disease virus (RHDV) - a Lagovirus belonging to the family Caliciviridae is the etiological agent of RHD. Typically, RHD presents with sudden death in 70% to 95% of infected animals. There have been four separate incursions of RHDV in the USA, the most recent of which occurred in the state of Indiana in June of 2005. Animal inoculation studies confirmed the pathogenicity of the Indiana 2005 isolate, which caused acute death and pathological changes characterized by acute diffuse severe liver necrosis and pulmonary hemorrhages. Complete viral genome sequences of all USA outbreak isolates were determined and comparative genomics revealed that each outbreak was the result of a separate introduction of virus rather than from a single virus lineage. All of the USA isolates clustered with RHDV genomes from China, and phylogenetic analysis of the major capsid protein (VP60) revealed that they were related to a pandemic antigenic variant strain known as RHDVa. Rapid spread of the RHDVa pandemic suggests a selective advantage for this new subtype. Given its rapid spread, pathogenic nature, and potential to further evolve, possibly broadening its host range to include other genera native to the Americas, RHDVa should be regarded as a threat.
Subject(s)
Caliciviridae Infections/veterinary , Disease Outbreaks , Genome, Viral , Hemorrhagic Disease Virus, Rabbit/genetics , Rodent Diseases/epidemiology , Animals , Antigens, Viral/genetics , Base Sequence , Caliciviridae Infections/epidemiology , Caliciviridae Infections/pathology , Hemorrhage/pathology , Hemorrhagic Disease Virus, Rabbit/isolation & purification , Hemorrhagic Disease Virus, Rabbit/pathogenicity , Indiana/epidemiology , Liver/pathology , Lung/pathology , Molecular Sequence Data , Necrosis/pathology , Phylogeny , Rabbits , Reverse Transcriptase Polymerase Chain Reaction , Rodent Diseases/virology , Viral Structural Proteins/genetics , VirulenceABSTRACT
The data were recorded during a Rabbit haemorrhagic disease outbreak that occurred in France in 2001 in a wild population of rabbits that we have been monitoring since 2000. These data suggested the existence of non-protective antibodies due to a putative RHDV-like virus. Twenty-one blood and 22 liver samples were taken from the 26 corpses of recently dead rabbits that were found. RHDV was found in all liver samples. A first screening for RHD antibodies, carried out using an ELISA based on the detection of VP60-RHDV antigen, showed that 20 of the rabbits were seropositive. Moreover, we determined antibody titres for 13 of these 20 seropositive samples. All were > or = 1/400. Such titres normally indicate antibody levels sufficient to confer protection to all known RHDV or RHDV-like strains. For 16 samples, we determined whether these rabbits had died of a chronic or an acute form of the disease, by employing monoclonal antibody (Mabs)--based differential ELISA. All had died of an acute form of RHD. Because the antibodies detected by this VP60-ELISA test are known to appear 5-6 days after infection and since acute RHD generally kills the rabbits 2-3 days after infection, we assumed that the detected antibodies must have been present before the exposure to the virus that killed these rabbits. A second detection of antibodies was made with Mabs that are specific for RHDV. The results were negative, showing that the antibodies detected with the VP60 ELISA test were not specific for RHDV. We sequenced a portion of the VP60 gene of viruses isolated in 17 rabbits. All RHDV isolates were very similar to the RHDV strains commonly isolated in France during this period, suggesting that this viral strain was not a putative variant that is not neutralised by antibodies. Therefore we conclude that the detected antibodies were probably due to a RHDV-like virus that induces the production of detectable but non-protective antibodies.